Evaluation of pegylated interferon-α therapy efficacy in patients with inactive hepatitis B surface antigen carrier state
{{output}}
Objectives: Chronic HBV infection remains a global health challenge, with many patients progressing to cirrhosis and hepatocellular carcinoma (HCC), while inactive HBsAg carriers (IHC) are considered stable but still at risk for ... ...
